Clinical Trial Update: Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is testing a liposomal irinotecan-based combination therapy for metastatic colorectal cancer, currently recruiting in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Onivyde (liposomal irinotecan) (liposomal irinotecan)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: RECRUITING